Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
0.9200
+0.0760 (9.00%)
Mar 25, 2026, 5:20 PM CET
-72.46% (1Y)
| Market Cap | 25.66M -67.6% |
| Revenue (ttm) | 36.76M +14.2% |
| Net Income | -25.78M |
| EPS | -0.94 |
| Shares Out | 30.40M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 31,660 |
| Average Volume | 50,948 |
| Open | 0.8940 |
| Previous Close | 0.8440 |
| Day's Range | 0.8940 - 0.9200 |
| 52-Week Range | 0.7600 - 3.4400 |
| Beta | 1.22 |
| RSI | 37.69 |
| Earnings Date | Apr 15, 2026 |